OncoHost
Latest round
- Series C
Last raised
- May 2022
Total raised
- $43M
Investors
- 4
About OncoHost
OncoHost, Inc.Founded in 2017, OncoHost, Inc. focuses on precision oncology, offering services that analyze patient samples to improve cancer treatment strategies.OncoHost specializes in precision oncology solutions, primarily through its flagship product, the PROphet® platform. This innovative system leverages bioinformatic proteomic pattern recognition and artificial intelligence to generate personalized PROphet® scores, which predict the efficacy of PD-1/PD-L1 inhibitors for cancer treatment. The testing process involves analyzing plasma or serum samples taken from patients before they start therapy, providing insights into tumor biology and host microenvironment interactions. By focusing on resistance mechanisms in immunotherapy for lung cancer and other malignancies, OncoHost aims to enhance clinical decision-making and patient outcomes.Revenue generation for OncoHost is primarily derived from its diagnostic testing services, specifically through the PROphet® test and the developing NeutroFlow test, which guides cancer therapy selection. The company operates on a direct-to-consumer model, where healthcare providers can order tests for their patients, leading to subsequent analysis and reporting services. Transactions are structured as service fees charged per test conducted, with potential subscription models for healthcare institutions seeking ongoing access to OncoHost's proprietary analytics and insights. The company is expected to design and launch new products, enhancing its existing offerings in precision oncology. Furthermore, OncoHost is looking to expand its operations into new markets, specifically targeting additional regions across North America and Europe by the end of 2025.
Who invested in OncoHost
4 investors across 2 rounds
See all investors in OncoHost
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about OncoHost
Who invested in OncoHost?
OncoHost has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OncoHost raised?
OncoHost has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did OncoHost last raise money?
OncoHost's most recent round on record is a Series C, in May 2022.
What does OncoHost do?
OncoHost is a biotechnology company.
Where is OncoHost headquartered?
OncoHost is headquartered in Israel.
Which VCs invest in companies like OncoHost?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at OncoHost's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like OncoHost? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.